Is combining methotrexate and leflunomide a safe option for treating rheumatoid arthritis?
Rheumatoid arthritis (RA) is a chronic immune-mediated disease marked by synovial inflammation and systemic features. Early management typically relies on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), with methotrexate (Mtx) serving as the primary therapeutic agent. When M...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society of Turaz Bilim
2025-04-01
|
| シリーズ: | Medicine Science |
| 主題: | |
| オンライン･アクセス: | https://www.medicinescience.org/?mno=257946 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|